SEC Form 4 · accession 0001179110-16-025778
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fredric N Eshelman
Director
Period of report
May 26, 2016
Accepted (ET)
May 31, 2016 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 26, 2016 | A | 3,426 | $0.00 | A | 303,426 | D | |
| Common StockF2 | holding | — | — | — | 944,537 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F3 | $37.22 | May 26, 2016 | A | 14,700 | A | — | May 26, 2026 | Common Stock | 14,700 | 14,700 | D |
Explanation of responses
- F1This restricted stock award vests on May 26, 2017 and is made as part of and pursuant to Issuer's director compensation package.
- F2These shares of the issuer's common stock are owned by Eshelman Ventures, LLC, an entity wholly owned by the reporting person.
- F3This option vests in one installment on May 26, 2017 and is made as part of and pursuant to Issuer's director compensation package.